Evidence map›Paper›PMID 32111615›Full record

ArticleBMJ open2020

Shared decision-making in advanced kidney disease: a scoping review protocol.

Noel Engels, Gretchen de Graav, Paul van der Nat, Marinus van den Dorpel, Willem Jan Bos, Anne M Stiggelbout

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Dialysis in the Elderly: A Practical Guide for the Clinician.International journal of nephrology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Supporting Shared Decision-Making and Home Dialysis in End-Stage Kidney Disease.International journal of nephrology and renovascular disease · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Noel EngelsShared decision making, Santeon, Utrecht, Utrecht, The Netherlands n.engels@santeon.nl.ORCID 0000-0002-5101-554X
Gretchen de GraavInternal Medicine, Maasstad Ziekenhuis, Rotterdam, Zuid-Holland, The Netherlands.
Paul van der NatSint Antonius Ziekenhuis, Nieuwegein, Utrecht, The Netherlands.
Marinus van den DorpelInternal Medicine, Maasstad Ziekenhuis, Rotterdam, Zuid-Holland, The Netherlands.
Willem Jan BosInternal Medicine, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
Anne M StiggelboutMedical Decision Making, Leiden University Medical Center, Leiden, Zuid Holland, The Netherlands.ORCID 0000-0002-6293-4509

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients with advanced kidney disease (AKD) have to make difficult treatment modality decisions as their disease progresses towards end-stage kidney disease. International guidelines in nephrology suggest shared decision-making (SDM) to help patients make timely treatment modality decisions that align with their values and preferences. However, systematic reviews or scoping reviews on these SDM interventions and on their reported use or outcomes are lacking. This limits the adoption of SDM in clinical practice and hampers further research and development on the subject. Our aim is to provide a comprehensive and up-to-date overview of these SDM interventions by means of a scoping review of the literature. Scoping reviews can provide a broad overview of a topic, identify gaps in the research knowledge base and report on the types of evidence that address and inform practices. This paper presents our study protocol. METHODS AND ANALYSIS: The proposed scoping review will be performed in accordance with the Joanna Briggs Institute's (JBI) methodology for scoping reviews. It will cover both qualitative and quantitative scientific literature, as well as the grey literature on SDM interventions for treatment modality decisions in AKD. Only literature written in English will be considered for inclusion. Two independent reviewers will participate in an iterative process of screening the literature, paper selection and data extraction. Disagreements between the reviewers will be resolved by discussion until consensus is reached or after consultation with the research team when needed. Results will be reported with descriptive statistics and diagrammatic or tabular displayed information, accompanied by narrative summaries as explained in the JBI guidelines. ETHICS AND DISSEMINATION: Ethical approval for the conduct of this study is not required. We will analyse previously collected data for the proposed scoping review. Our results will be published in a peer-reviewed journal and disseminated through conferences and/or seminars.

Indexed as

Decision Making, SharedHumansKidney DiseasesResearch DesignScoping Reviews as Topicadvanced kidney diseaseoutcome measuresprotocolscoping reviewshared decision-makingtreatment modality

Identifiers

PMID32111615
PMCPMC7050317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.